Mannino D M, Holguin F, Pavlin B I, Ferdinands J M
Division of Pulmonary and Critical Care Medicine, Chandler Medical Center, University of Kentucky, Lexington, Kentucky 40536, USA.
Int J Tuberc Lung Dis. 2005 Jun;9(6):613-21.
To define risk factors for both restriction on spirometry and subsequent mortality in a national cohort of US adults.
Participants in the First National Health and Nutrition Examination Survey (NHANES I) were followed for up to 22 years. Subjects were classified using the forced expiratory volume in one second (FEV1), the forced vital capacity (FVC), and the FEV1/FVC ratio into subgroups with and without restriction on spirometry. Regression models were developed to determine risk factors for restriction on spirometry and death.
Our final cohort consisted of 4320 subjects, of whom 481 (10.3 weighted %) had restriction on spirometry. The largest risk factors for restriction on spirometry were a cardiothoracic ratio of >55% (OR 4.3, 95%CI 3.1-5.9), race other than black or white (OR 3.7, 95%CI 1.8-7.8), and a history of stroke or paralysis (OR 1.8, 95%CI 1.1-2.9). The overall mortality rate was increased in subjects with restriction on spirometry (25.7 vs. 10.3 deaths per 1000 person-years).
Restriction on spirometry is associated with comorbid disease and increased mortality, and is present in a significant proportion of the population.
确定美国成年人群队列中肺活量测定受限及随后死亡率的风险因素。
对首次全国健康与营养检查调查(NHANES I)的参与者进行了长达22年的随访。根据一秒用力呼气容积(FEV1)、用力肺活量(FVC)和FEV1/FVC比值将受试者分为肺活量测定受限和不受限的亚组。建立回归模型以确定肺活量测定受限和死亡的风险因素。
我们的最终队列包括4320名受试者,其中481名(加权比例为10.3%)肺活量测定受限。肺活量测定受限的最大风险因素是心胸比率>55%(比值比4.3,95%置信区间3.1 - 5.9)、非黑人或白人种族(比值比3.7,95%置信区间1.8 - 7.8)以及中风或瘫痪病史(比值比1.8,95%置信区间1.1 - 2.9)。肺活量测定受限的受试者总体死亡率有所增加(每1000人年25.7例死亡对10.3例死亡)。
肺活量测定受限与合并疾病及死亡率增加相关,且在相当比例的人群中存在。